A history of previous gestational diabetes mellitus is associated with adverse changes in insulin secretion and VLDL metabolism independently of increased intrahepatocellular lipid

Diabetologia

Volumn 56, Issue 9, 2013, Pages 2021-2033

  Forbes, S ^a,b   Godsland, I F ^b   Taylor Robinson, S D ^b   Bell, J D ^b   Thomas, E L ^b   Patel, N ^b   Hamilton, G ^b   Parker, K H ^b   Marshall, I ^a   Gray, C D ^c   Bedford, D ^d   Caslake, M ^d   Walker, B R ^a   Johnston, D G ^b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Acute insulin response to glucose; Adiposity; Disposition index; Gestational diabetes; Insulin resistance; Non alcoholic fatty liver disease; Type 2 diabetes; VLDL metabolism

Indexed keywords

APOLIPOPROTEIN B; FATTY ACID; INTRAHEPATOCELLULAR LIPID; LIPID; PALMITIC ACID; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; BODY FAT; CONTROLLED STUDY; DISEASE ASSOCIATION; FATTY ACID METABOLISM; FEMALE; HUMAN; INSULIN RELEASE; INSULIN RESPONSE; INSULIN SENSITIVITY; LIPID ANALYSIS; LIPID STORAGE; LIPOPROTEIN METABOLISM; LIPOPROTEIN SYNTHESIS; MAJOR CLINICAL STUDY; MEDICAL HISTORY; MOLECULAR DYNAMICS; NONALCOHOLIC FATTY LIVER; OBESITY; PHENOTYPE; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE;

ADULT; DIABETES MELLITUS, TYPE 2; DIABETES, GESTATIONAL; FATTY LIVER; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; LIPOPROTEINS, VLDL; LIVER; PREGNANCY;

EID: 84881614020     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-013-2956-3     Document Type: Article

References (49)

1. Ryan EA, Imes S, Liu D et al (1995) Defects in insulin secretion and action in women with a history of gestational diabetes. Diabetes 44:506-512
2. Retnakaran R (2009) Glucose tolerance status in pregnancy: a window to the future risk of diabetes and cardiovascular disease in young women. Curr Diabetes Rev 5:239-244
3. Angulo P (2002) Nonalcoholic fatty liver disease. N Engl J Med 346:1221-1231
4. Targher G, Bertolini L, Padovani R et al (2007) Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients. Diabetes Care 30:1212-1218
5. Mehta SR, Godsland IF, Thomas EL et al (2012) Intrahepatic insulin exposure, intrahepatocellular lipid and regional body fat in nonalcoholic fatty liver disease. J Clin Endocrinol Metab 97:2151-2159
6. Bozkurt L, Gobl CS, Tura A et al (2012) Fatty liver index predicts further metabolic deteriorations in women with previous gestational diabetes. PLoS One 7:e32710
7. Tiikkainen M, Tamminen M, Hakkinen AM et al (2002) Liver-fat accumulation and insulin resistance in obese women with previous gestational diabetes. Obes Res 10:859-867
8. Forbes S, Taylor-Robinson SD, Patel N, Allan P, Walker BR, Johnston DG (2011) Increased prevalence of non-alcoholic fatty liver disease in European women with a history of gestational diabetes. Diabetologia 54:641-647
9. Williamson RM, Perry E, Glancy S et al (2011) The use of ultrasound to diagnose hepatic steatosis in type 2 diabetes: intra- and interobserver variability and comparison with magnetic resonance spectroscopy. Clin Radiol 66:434-439
10. Saadeh S, Younossi ZM, Remer EM et al (2002) The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 123:745-750
11. Thomas EL, Saeed N, Hajnal JV et al (1998) Magnetic resonance imaging of total body fat. J Appl Physiol 85:1778-1785
12. Thomas EL, Hamilton G, Patel N et al (2005) Hepatic triglyceride content and its relation to body adiposity: a magnetic resonance imaging and proton magnetic resonance spectroscopy study. Gut 54:122-127
13. Forbes S, Robinson S, Dungu J et al (2006) Sustained endogenous glucose production, diminished lipolysis and non-esterified fatty acid appearance and oxidation in non-obese women at high risk of type 2 diabetes. Eur J Endocrinol 155:469-476
14. Godsland IF, Johnston DG (2008) Co-associations between insulin sensitivity and measures of liver function, subclinical inflammation, and hematology. Metab Clin Exp 57:1190-1197
15. Webber J, Taylor J, Greathead H, Dawson J, Buttery PJ, Macdonald IA (1995) The effects of fasting on the thermogenic, metabolic and cardiovascular responses to infused adrenaline. Br J Nutr 74:477-490
16. Chrisoulidou A, Kousta E, Venkatesan S et al (1999) Very-low-density lipoprotein apolipoprotein B100 kinetics in adult hypopituitarism. Metab Clin Exp 48:1057-1062
17. Institute NHaL (1975) Manual of laboratory operations: Lipid Research Clinics Program. US Department of Health, Education and Welfare, Bethesda
18. Havel RJ, Eder HA, Bragdon JH (1955) The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 34:1345-1353
19. Gill JM, Brown JC, Caslake MJ et al (2003) Effects of dietary monounsaturated fatty acids on lipoprotein concentrations, compositions, and subfraction distributions and on VLDL apolipoprotein B kinetics: dose-dependent effects on LDL. Am J Clin Nutr 78:47-56
20. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275
21. Adiels M, Boren J, Caslake MJ et al (2005) Overproduction of VLDL1 driven by hyperglycemia is a dominant feature of diabetic dyslipidemia. Arterioscler Thromb Vasc Biol 25:1697-1703
22. Naressi A, Couturier C, Devos JM et al (2001) Java-based graphical user interface for the MRUI quantitation package. MAGMA 12:141-152
23. Levy JC, Matthews DR, Hermans MP (1998) Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care 21:2191-2192
24. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419
25. Bergman RN (1989) Lilly lecture 1989. Toward physiological understanding of glucose tolerance. Minimal-model approach. Diabetes 38:1512-1527
26. Godsland IF, Agbaje OF, Hovorka R (2006) Evaluation of nonlinear regression approaches to estimation of insulin sensitivity by the minimal model with reference to Bayesian hierarchical analysis. Am J Physiol 291:E167-E174
27. Swan JW, Walton C, Godsland IF (1994) Assessment of insulin sensitivity in man: a comparison of minimal model- and euglycaemic clamp-derived measures in health and heart failure. Clin Sci (Lond) 86:317-322
28. Godsland IF, Jeffs JA, Johnston DG (2004) Loss of beta cell function as fasting glucose increases in the non-diabetic range. Diabetologia 47:1157-1166
29. Matthews JN, Altman DG, Campbell MJ, Royston P (1990) Analysis of serial measurements in medical research. BMJ (Clin Res Ed) 300:230-235
30. Wolfe RR (ed) (1992) Radioactive and stable isotope tracers in biomedicine: principles and practice of kinetic analysis. Wiley-Liss, Chichester
31. Patterson BW, Zhao G, Elias N, Hachey DL, Klein S (1999) Validation of a new procedure to determine plasma fatty acid concentration and isotopic enrichment. J Lipid Res 40:2118-2124
32. Kearney T, de Gallegos CN, Proudler A et al (2003) Effects of short- and long-term growth hormone replacement on lipoprotein composition and on very-low-density lipoprotein and low-density lipoprotein apolipoprotein B100 kinetics in growth hormone-deficient hypopituitary subjects. Metab Clin Exp 52:50-59
33. Fabbrini E, Mohammed BS, Korenblat KM et al (2010) Effect of fenofibrate and niacin on intrahepatic triglyceride content, very low-density lipoprotein kinetics, and insulin action in obese subjects with nonalcoholic fatty liver disease. J Clin Endocrinol Metab 95:2727-2735
34. Angulo P, Lindor KD (2002) Non-alcoholic fatty liver disease. J Gastroenterol Hepatol 17(Suppl):S186-S190
35. Forbes S, Moonan M, Robinson S et al (2005) Impaired circulating glucagon-like peptide-1 response to oral glucose in women with previous gestational diabetes. Clin Endocrinol 62:51-55
36. Lorenzo C, Wagenknecht LE, Rewers MJ et al (2010) Disposition index, glucose effectiveness, and conversion to type 2 diabetes: the Insulin Resistance Atherosclerosis Study (IRAS). Diabetes Care 33:2098-2103
37. Kwak SH, Choi SH, Jung HS et al (2013) Clinical and genetic risk factors for type 2 diabetes at early or late post partum after gestational diabetes mellitus. J Clin Endocrinol Metab 98:E744-E752
38. Petry CJ, Hales CN (2000) Long-term effects on offspring of intrauterine exposure to deficits in nutrition. Hum Reprod Update 6:578-586
39. Seltzer HS, Allen EW, Herron AL Jr, Brennan MT (1967) Insulin secretion in response to glycemic stimulus: relation of delayed initial release to carbohydrate intolerance in mild diabetes mellitus. J Clin Invest 46:323-335
40. Cohen JC, Horton JD, Hobbs HH (2011) Human fatty liver disease: old questions and new insights. Science 332:1519-1523
41. Retnakaran R, Qi Y, Connelly PW, Sermer M, Hanley AJ, Zinman B (2010) The graded relationship between glucose tolerance status in pregnancy and postpartum levels of low-density-lipoprotein cholesterol and apolipoprotein B in young women: implications for future cardiovascular risk. J Clin Endocrinol Metab 95:4345-4353
42. Packard CJ, Shepherd J (1997) Lipoprotein heterogeneity and apolipoprotein B metabolism. Arterioscler Thromb Vasc Biol 17:3542-3556
43. Adiels M, Olofsson SO, Taskinen MR, Boren J (2008) Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome. Arterioscler Thromb Vasc Biol 28:1225-1236
44. Fabbrini E, deHaseth D, Deivanayagam S, Mohammed BS, Vitola BE, Klein S (2009) Alterations in fatty acid kinetics in obese adolescents with increased intrahepatic triglyceride content. Obesity (Silver Spring) 17:25-29
45. Hellerstein MK (2012) Mitigating factors and metabolic mechanisms in fructose-induced nonalcoholic fatty liver disease: the next challenge. Am J Clin Nutr 96:951-952
46. Prikoszovich T, Winzer C, Ingo Schmid A et al (2011) Body and liver fat mass rather than muscle mitochondrial function determine glucose metabolism in women with a history of gestational diabetes mellitus. Diabetes Care 34:430-436
47. Pagano G, Pacini G, Musso G et al (2002) Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association. Hepatology 35:367-372
48. Thomas EL, Parkinson JR, Frost GS et al (2012) The missing risk: MRI and MRS phenotyping of abdominal adiposity and ectopic fat. Obesity (Silver Spring) 20:76-87
49. Ortiz-Lopez C, Lomonaco R, Orsak B et al (2012) Prevalence of prediabetes and diabetes and metabolic profile of patients with nonalcoholic fatty liver disease (NAFLD). Diabetes Care 35:873-878